These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23845255)

  • 21. Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis.
    Ravegnini G; Nannini M; Sammarini G; Astolfi A; Biasco G; Pantaleo MA; Hrelia P; Angelini S
    Int J Mol Sci; 2015 Jul; 16(7):15592-608. PubMed ID: 26184165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: four cases of rare tumors and a review of the literature.
    Afşar CU; Kara IO; Kozat BK; Demiryürek H; Duman BB; Doran F
    Crit Rev Oncol Hematol; 2013 May; 86(2):191-9. PubMed ID: 23218951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases.
    Zhang L; Smyrk TC; Young WF; Stratakis CA; Carney JA
    Am J Surg Pathol; 2010 Jan; 34(1):53-64. PubMed ID: 19935059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Novel molecular-targeted agents for GIST(Regorafenib etc.)].
    Naito Y; Doi T
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):15-8. PubMed ID: 23306914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in the management of gastrointestinal stromal tumors.
    Yip D; Zalcberg J; Ackland S; Barbour AP; Desai J; Fox S; Kotasek D; McArthur G; Smithers BM
    Asia Pac J Clin Oncol; 2014 Sep; 10(3):216-27. PubMed ID: 24673914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Additional primary malignancies in patients with gastrointestinal stromal tumors. Proposal for a new classification].
    Fernández Hernández JÁ; Olivares Ripoll V; Parrilla Paricio P
    Med Clin (Barc); 2016 Nov; 147(9):405-409. PubMed ID: 27431886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gastrointestinal stromal tumors (GIST): The particularities aspects in African countries].
    Togo A; Traoré A; Dembélé BT; Diakité I; Traoré A; Konaté M; Bah A; Kanté L; Koné T; Dicko MY; Yoro Sidibé B; Ahmadou I; Diallo G
    Bull Cancer; 2018 Feb; 105(2):212-213. PubMed ID: 29397915
    [No Abstract]   [Full Text] [Related]  

  • 28. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
    Wu X; Li J; Xu W; Gao J; Li Y; Shen L
    Future Oncol; 2018 Jul; 14(17):1721-1729. PubMed ID: 29969914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal stromal tumor and isolated anterior tibial muscle metastasis as first recurrence.
    Mutlu H; Balkarlı H; Musri FY; Salim DK; Eryılmaz MK; Ünal B; Coşkun HŞ
    J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medical therapy of GIST; from palliative to curative treatment].
    Le Cesne A; Blay JY
    Bull Acad Natl Med; 2012; 196(4-5):861-74; discussion 874-76. PubMed ID: 23550449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous occurrence of synchronous and metachronous tumors with gastrointestinal stromal tumors.
    Adim SB; Filiz G; Kanat O; Yerci O
    Bratisl Lek Listy; 2011; 112(11):623-5. PubMed ID: 22180988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two out of three required: a case of incomplete Carney triad.
    Slevin F; Duncan P; Shenjere P; Leahy M; Evans G; Sherlock D
    Int J Surg Pathol; 2012 Jun; 20(3):265-8. PubMed ID: 21791484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of regorafenib for the treatment of gastrointestinal stromal tumors.
    Rutkowski P; Stępniak J
    Expert Opin Drug Saf; 2016 Jan; 15(1):105-16. PubMed ID: 26651387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GISTs' classifications in predicting aggressive behavior: a single institution experience.
    Separović R; Silovski T; Pavlović M; Silovski H; Dmitrović B; Kurbel S
    Coll Antropol; 2013 Sep; 37(3):977-84. PubMed ID: 24308246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastrointestinal stromal tumor (GIST): advances in 2013].
    Daum O; Sedivcová M
    Cesk Patol; 2014 Apr; 50(2):76-80. PubMed ID: 24758502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis].
    Bettegazzi C; Erra S
    Recenti Prog Med; 2015 Jan; 106(1):52-7. PubMed ID: 25621782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
    Caram MV; Schuetze SM
    J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of submucosal tumors in the gastrointestinal tract.
    Ponsaing LG; Kiss K; Hansen MB
    World J Gastroenterol; 2007 Jun; 13(24):3311-5. PubMed ID: 17659669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal stromal tumors (GIST) in children and adolescents: A comprehensive review of the current literature.
    Benesch M; Wardelmann E; Ferrari A; Brennan B; Verschuur A
    Pediatr Blood Cancer; 2009 Dec; 53(7):1171-9. PubMed ID: 19499582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.